MedTrace Logo

Study of T-PRED(TM) Compared to Pred Forte(R)

NCT00699803 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2020-09-25

Study results available
· View outcomes & findings →

Summary

Study of T-PRED(TM) compared to Pred Forte(R)

Conditions

  • Cataract

Interventions

DRUG

T-PRED

T-PRED sterile ophthalmic solution

DRUG

Pred Forte

Pred Forte sterile ophthalmic solution

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Tim McNamara, PharmD · ISTA Pharmaceuticals, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00699803 on ClinicalTrials.gov